Breast Cancer Now hits out at drug rejection for breast cancer patients Clinical Services Journal 09:48 Thu, 15 Oct
Vamstar wins $1.2M Innovate UK Sovereign AI funding to show health technology developers what payers will accept before trial designs are locked Pressat (Press Release) 13:49 Mon, 05 Oct
NICE recommends Enhertu for people with HER2-low advanced breast cancer Clinical Services Journal 12:14 Thu, 24 Sep